ARCHIVES

FDA Approves Generic Oncology Injectable Currently In Shortage

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Two activists Are Appointed To Complete NCAB

May 31, 1991

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Board Commends M.D. Anderson On 50th Year

May 17, 1991

Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care

August 26, 2011

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012